Paediatric rheumatologists in two specialist centres in the UK are calling for international collaboration to refine a promising treatment for children with severe juvenile idiopathic arthritis (JIA) when other options have failed. The treatment is intense immunosuppression followed by autologous haemopoietic stem cell transplantation (ASCT), and future steps are understanding …